Calling everyone impacted by vitiligo! Help us advocate for more treatment options.
There is a new drug called ruxolitinib that is being considered by Health Canada for its potential in treating vitiligo.
Take the Survey!We want to more learn about your experience living with vitiligo and with vitiligo treatments. If you are a patient or a loved one, we invite you to take this 20-minute survey to help inform our advocacy efforts for people impacted by vitiligo.
It is available in both English and French.
Calling all prurigo nodularis patients and caregivers! Help us advocate for more treatment options.
There is a new drug called nemolizumab that is being considered by Health Canada for its potential in treating prurigo nodularis.
Take the Survey!We want to more learn about your experience with prurigo nodularis treatments. If you are a patient or a loved one, we invite you to take this 15-minute survey to help inform our advocacy efforts for people impacted by prurigo nodularis.
It is available in both English and French.
Help shape virtual care in Ontario!
This study, Survey of Patients' Experiences with Virtual Care Across Ontario, invites Ontario residents to complete a survey to share experiences and suggestions on how to improve virtual health care in primary care settings.
As a survey participant, you will:
• Complete a 15-to-20-minute anonymous, online survey
• Inform patient-centred recommendations to the Ontario government regarding how to provide high quality health care through virtual care appointments
• Enter in a draw for $100 Amazon gift cards
Closed Surveys
Psoriasis patients and caregivers - your experience with psoriasis drugs
Acne patients - your experience with acne drugs
